Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

NCT03475953 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

NCT05141721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

NCT04117945 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy

NCT01538680 ·Status: NO_LONGER_AVAILABLE

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

NCT00628810 ·Status: COMPLETED ·Phase: PHASE2

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

NCT00975897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer

NCT00403052 ·Status: TERMINATED ·Phase: PHASE1

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)

NCT00483080 ·Status: COMPLETED ·Phase: PHASE2

Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer

NCT02068131 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients

NCT06169202 ·Status: RECRUITING

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

NCT02675946 ·Status: UNKNOWN ·Phase: PHASE1

A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer

NCT02096354 ·Status: COMPLETED ·Phase: PHASE2

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

NCT03592641 ·Status: TERMINATED ·Phase: PHASE2

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

NCT04708470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver

NCT00035919 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

NCT00611858 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)

NCT03063762 ·Status: COMPLETED ·Phase: PHASE1

Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer

NCT02110082 ·Status: COMPLETED ·Phase: PHASE1

Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

NCT03353753 ·Status: COMPLETED ·Phase: PHASE3

Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma

NCT01639131 ·Status: TERMINATED ·Phase: PHASE2

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

NCT00557102 ·Status: COMPLETED ·Phase: PHASE2

A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

NCT03597581 ·Status: COMPLETED ·Phase: PHASE1

Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

NCT02149108 ·Status: COMPLETED ·Phase: PHASE3

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

NCT00005085 ·Status: COMPLETED ·Phase: PHASE2